Research has also linked mutations in chromatin modifiers (ARID1A, BAP1, and KMT2C) with MUC5AC-positive IPNBs which are similar to mutations seen in CCA, which points to the possible aberrant epigenetic regulation of MUC5AC in BTC [116]. The gene discussed is MUC5AC; the disease is cholangiocarcinoma.